Acute Myeloid Leukemia

Slides:



Advertisements
Similar presentations
Susanna Akiki WMRGL 2009 Acute Promyelocytic Leukemia with t(15;17) (q22;q21) developing inv(16)(p13q22) secondary AML.
Advertisements

TA OGUNLESI (FWACP)1 CHILDHOOD LEUKAEMIA. TA OGUNLESI (FWACP)2 LEUKAEMIA Heterogenous group of malignant disorders Characterised by uncontrolled clonal.
Hematologic Malignancies CON 616, 2009
Approach to Acute Leukemia
MALIGNANCIES OF THE HAEMAPOIETIC STEM CELL. Haemapoietic Stem Cell are pluripotent and give rise to all of the haemopoietic cell under the action of cytokines.
Leukemia Leukemia is a general term for a group of malignancies of either lymphoid or hematopoietic cell origin.
Acute Myelogenous Leukemia and its Impact on the Immune System
Myelodysplastic Syndrome
LEUKEMIA.
LEUKEMIA—HEMATOLOGY {S1}
Acute myeloid leukemia Malignant clonal disorder of immature myeloid progenitor cells characterized by clonal proliferation of abnormal blast cells and.
Leukemias.
Retinoic Acid Receptor- Alpha and Its Role in Acute Promyelocytic Leukemia By Alex Sheng.
Notch1 and pre-T-cell Acute Lymphoblastic Leukemia (T-ALL) by Lindsey Wilfley.
Retinoic Acid Receptor Alpha (RARα) Acute Promyelocytic Leukemia (APL)
Retinoic Acid Receptor Alpha and Acute Promyelocytic Leukemia Nidhi Thapar April 1, 2004.
ACUTE MYELOID LEUKEMIA Irit Avivi
LEUKEMIAS Dr Mehboob Khan Pathologist
Acute leukemia Aggressive malignant hematopoietic disorders
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Chronic leukemias. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Chapter 25: Acute Lymphoblastic Leukemia. Causes a wide spectrum of syndromes – From involvement of bone marrow and peripheral blood(leukemias) to those.
Acute Myeloid Leukemias (AML)
Blood Cancer & Chromosome 21 By Manasi Shah. Core Binding Factor Acute Myeloid Leukemia (CBF-AML) AML is a type of cancer that affects bone marrow and.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Molecular Medicine Dr Catherine Flynn Consultant Haematologist St James’s Hospital October 22 nd 2009.
Jan Żeromski Pathology 2010/2011.  Malignant proliferation of white cells of the hematopoietic system with infestation of blood and usually bone marrow.
C HRONIC LEUKEMIAS. Chronic myelogenous (granulocytic) leukemia Is characterized by an unregulated proliferation of myeloid elements in the bone marrow,
Acute Leukemia and the FLT3 Receptor B y: Betty Sa’ Mentor: Dr. Govind Bhagat Site: Columbia University Vanderbilt Clinic.
Normal haemopoiesis. ABNORMALITIES IN THE HEMOPOIETIC SYSTEM CAN LEAD TO HEMOGLOBINOPATHIES HEMOPHILIA DEFECTS IN HEMOSTASIS/THROMBOSIS HEMATOLOGICAL.
Acute promyelocytic leukemia (APL) From the worst to the best prognosis MUDr. Petr Pavlíček Internal Hematological Clinics FNKV and 3LF UK in Prague.
ICCS e-Newsletter CSI Fall 2010 David D. Grier, M.D. Department of Pathology. Wake Forest University.
4th Year Medical Student KAU
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Clinical laboratory diagnostics of hemoblastosis.
PATH 430 MOLECULAR BASIS OF DISEASE MICHAEL RAUH, MD, PHD JANUARY 18, 2016.
Leukaemias. Leukaemias: Malignant Disease of WBC Forming tissue or other hemopoietic elements: Lymphoblastic (ALL) Lymphoblastic (ALL)Acute Myeloid (AML)
MLAB 1415: Hematology Keri Brophy-Martinez
The Role of Nucleophosmin in Acute Myelogenous Leukemia Erik Olsson.
MLAB Hematology Keri Brophy-Martinez
White blood cells and their disorders Dr K Hampton Haematologist Royal Hallamshire Hospital.
Acute Leukemia Kristine Krafts, M.D..
Retinoic Acid Receptor α Acute Promyelocytic Leukemia Michi Nair.
Hematopoietic Cancers Common Disruptions
Hematology There are four lectures: 1.Acute leukemias (2 hours). 2.Chronic leukemias (2 hours).
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives chronic myeloid leukaemia (CML) Haematopoietic malignancies Polycythemia vera (PV) Idiopathic myelofibrosis.
Acute Leukemia Kristine Krafts, M.D..
Malignancies of hematopoietic cells. Leukemia
Childhood leukemias Prof. Dr. P. Kajtár.
Acute myeloid leukemia
Acute Myeloid Leukemia
LEUKEMIAS H.A. MWAKYOMA, MD.
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
Chronic Leukaemias Heterogeneous group of hematopoietic neoplasms
CHRONIC MYELOID LEUKEMIA (CML)
17 Chapter 17: Chromosome 17 Nucleus 48,473 bp 882 aa RARA Cytoplasm
Misleading acute promyelocytic leukemia morphology
Leukemia Case 1.
Case Study ….
Case:2 leukemia دينا نعمان جرادة جيهان ايمن مقاط.
Acute leukemia.
Diagnostic Hematology
Lymphoma Ali Al Khader, M.D. Faculty of Medicine
Erythroid maturation.
بسم الله الرحمن الرحيم Acute lymphoid leukemia(ALL) Prepared by ::
A presentation By Abedelaziz Taha Hammash supervisor \ Mr
Acute Leukemia Dr. Noha Noufal.
Chronic Leukemia Dr. Noha Noufal.
CHRONIC LEUKEMIA BY: DR. FATMA AL-QAHTANI CONSULTANT HAEMATOLOGIST
MYELOID LEUKEMIAS Dr. B.V.Vydehi M.D PROFESSOR OF PATHOLOGY
Presentation transcript:

Acute Myeloid Leukemia Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University Email: ali.alkhader@bau.edu.jo

Overview Originate from transformed hematopoietic progenitors …due to acquired oncogenic mutations that impede differentiation …leading to: Accumulation of immature myeloid forms (blasts) in the bone marrow suppresses normal hematopoiesis The replacement of the marrow with blasts produces marrow failure and complications related to anemia, thrombocytopenia, and neutropenia

Overview, cont’d Occurs at all ages, but the incidence rises throughout life, peaking after 60 years of age The current WHO classification subdivides AML into four categories …see next slide

Pathogenesis Most AMLs harbor mutations in genes encoding transcription factors that are required for normal myeloid cell differentiation …defective maturation of early myeloid cells resulting in the accumulation of myeloid precursors (blasts) in the marrow Of particular interest is the (15;17) translocation in acute promyelocytic leukemia …results in the fusion of the retinoic acid receptor α (RARA) gene on chromosome 17 and the PML gene on chromosome 15 …the chimeric gene produces a PML/RARα fusion protein that blocks myeloid differentiation at the promyelocytic stage …probably in part by inhibiting the function of normal retinoic acid receptors …Pharmacologic doses of all-trans retinoic acid (ATRA), an analogue of vitamin A can be used…also its combination with arsenic trioxide (a salt that induces the degradation of the PML/RARA fusion protein) can cure 80% of patients

Pathogenesis, cont’d Some of the other mutations implicated in AML have no effect on differentiation but instead enhance cellular proliferation and survival …examples: - FLT3, a receptor tyrosine kinase - RAS

Morphology By definition, in AML myeloid blasts or promyelocytes make up more than 20% of the bone marrow cellular component Myeloblasts (precursors of granulocytes) -delicate nuclear chromatin -three to five nucleoli -fine azurophilic cytoplasmic granules -Auer rods, distinctive red-staining rod-like structures..may be present in myeloblasts or more differentiated cells …they are particularly numerous in acute promyelocytic leukemia …Auer rods are specific for neoplastic myeloblasts and thus a helpful diagnostic clue when present In other subtypes of AML, monoblasts, erythroblasts, or megakaryoblasts predominate

Morphology, cont’d

Clinical notes Splenomegaly and lymphadenopathy generally are less prominent than in ALL On rare occasions AML mimics a lymphoma by manifesting as a discrete tissue mass (a so-called granulocytic sarcoma)

Clinical notes, cont’d The overall survival in all patients is only 15% to 30% with conventional chemotherapy t(8,21) and inv16 are good Hematopoietic stem cell transplantation…sometimes used

Diagnosis The diagnosis and classification of AML are based on: -morphologic -histochemical -immunophenotypic -karyotypic findings Of these, the karyotype (to detect translocations) is most predictive of outcome

Immunohistochemistry (Immunophenotype of tumor cells) myeloid-associated antigens: …CD13, CD14, CD15, CD64, CD117 (cKIT), or CD33

Thank You